COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,429 Articles (22,835 medRxiv, 8,594 bioRxiv)

Most recent first Previous |  Page 656: Articles 6551-6560  | Next

Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the United States
Cheng, M. M., Reyes, C., Satram, S., Birch, H., Gibbons, D. C., Drysdale, M., Bell, C. F., Suyundikov, A., Ding, X., Maher, M. C., Yeh, W., Telenti, A., Corey, L.
10.1101/2022.09.07.22279497 — Posted: 2022-09-11
LEAF- 4L6715 enhances oxygenation in patients with acute respiratory distress syndrome (ARDS) due to severe COVID-19: Final results of a phase I/II clinical trial
Mertes, P.-M., Delabranche, X., Coliat, P., Roche, A.-C., Collange, O., Voegelin, M., Bernard, A., Dhindsa, N., Xu, H., Geng, B., Niyikiza, C., Moyo, V., Bourbon, C., Villa, P., Detappe, A., Pivot, X.
10.1101/2022.09.07.22279668 — Posted: 2022-09-10
Noninvasive diagnosis of secondary infections in COVID-19 by sequencing of plasma microbial cell-free DNA.
Lisius, G. L., Duttagupta, R., Ahmed, A., Hensley, M., Al-Yousif, N., Lu, M., Bain, W., Shah, F., Schaefer, C., Qin, S., Wang, X., Zhang, Y., Kevin, M., Hughes, E., Jacobs, J., Naqvi, A., Haidar, G., Mellors, J., Methe, B., McVerry, B., Morris, A., Kitsios, G.
10.1101/2022.09.09.22279790 — Posted: 2022-09-10
A phase 3, randomised, double-blind, placebo-controlled clinical trial for adult evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine (ABDALA-3 Study).
Hernandez-Bernal, F., Ricardo-Cobas, M. C., Martin-Bauta, Y., Rodriguez-Martinez, E., Urrutia-Perez, K., Urrutia-Perez, K., Quintana-Guerra, J., Navarro-Rodriguez, Z., Pinera-Martinez, M., Rodriguez-Reinoso, J. L., Chavez-Chong, C. O., Baladron-Castrillo, I., Melo-Suarez, G., Batista-Izquierdo, A., Pupo-Mico, A., Mora-Betancourt, R., Soler-Cano, D., Bizet-Almeida, J., Martinez-Rodriguez, M. C., Lobaina-Lambert, L., Velazquez-Perez, V. M., Soler-Diaz, J., Blanco-Garrido, Y., Laurencio-Vallina, S., Merino-Hechavarria, T., Carmenaty-Campos, N., Rodriguez-Montero, E., Limonta-Fernandez, M., Alonso-Valdes, M., Hernandez-Rodriguez, R., Pimentel Vazquez, E., Catasus-Alvarez, K. M., Cabrera-Nunez, M. V., Ayala-Avila, M., Muzio-Gonzalez, V. L.
10.1101/2022.09.08.22279690 — Posted: 2022-09-10
Population Normalization in SARS-CoV-2 Wastewater-Based Epidemiology: Implications from Statewide Wastewater Monitoring in Missouri
Li, C., Bayati, M., Hsu, S.-Y., Hsieh, H.-Y., Lindsi, W., Belenchia, A., Zemmer, S. A., Klutts, J., Samuelson, M., Reynolds, M., Semkiw, E., Johnson, H.-Y., Foley, T., Wieberg, C. G., Wenzel, J., Lyddon, T. D., LePique, M., Rushford, C., Salcedo, B. B., Young, K., Graham, M., Suarez, R., Ford, A., Antkiewicz, D. S., Janssen, K. H., Shafer, M. M., Johnson, M. C., Lin, C.-H.
10.1101/2022.09.08.22279459 — Posted: 2022-09-10
THE EFFECT OF THE MEASLES, MUMPS AND RUBELLA VACCINE ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN PERSONS RECEIVING A SARS-COV-2 mRNA VACCINE.A SUB-STUDY OF THE CROWN CORONATION TRIAL
du Toit, L., Gupta, A., Dehbi, H.-M., Darling, T. L., Urusova, D. V., Thirunavukkarasu, S., Boon, A. C., Dubberke, E. R., Yun, L., McKinnon, S., DeSchryver, A. K., Swan, B., Netea, M. G., Khader, S., Avidan, M. S.
10.1101/2022.09.09.22279771 — Posted: 2022-09-10
SARS-CoV-2 Serosurveys: How antigen, isotype and threshold choices affect the outcome
Binder, R. A., Fujimori, G. F., Forconi, C. S., Reed, G. W., Silva, L. S., Lakshmi, P. S., Higgins, A., Cincotta, L., Dutta, P., Salive, M.-C., Mangolds, V., Anya, O., Calvo Calle, J. M., Nixon, T., Tang, Q., Wessolossky, M., Wang, Y., Ritacco, D. A., Bly, C. S., Fischinger, S., Atyeo, C., Oluoch, P. O., Odwar, B., Bailey, J. A., Maldonado-Contreras, A., Haran, J. P., Schmidt, A. G., Cavacini, L., Alter, G., Moormann, A. M.
10.1101/2022.09.09.22279787 — Posted: 2022-09-10
Effectiveness of incentivized peer referral to increase enrollment in a community-based chlamydia screening and treatment study among young Black men
Campbell, M. B., Ratnayake, A., Gomes, G., Stoecker, C., Kissinger, P. J.
10.1101/2022.09.09.22279725 — Posted: 2022-09-10
Expression profiling of immune-response-genes common in SARS-CoV-1 and influenza A virus disease, viz-a-viz neutropenia disorder, using integrated bioinformatics tools
Olaniyi, A. C., Oluwadamilola, O. D., Oluwabunmi, A. T.
10.1101/2022.09.09.507303 — Posted: 2022-09-10
A new and highly effective method for predicting T-cell response targets implemented on SARS-CoV-2 data
Flegr, J., Zahradnik, D.
10.1101/2022.09.09.507307 — Posted: 2022-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).